Cancer Immunotherapy: Bridging Basic Research and Clinical Translation

The conference connects molecular immunology with therapeutic development in cancer. Researchers discuss resistance to checkpoint and cell-based therapies, targeting innate cells, emerging technologies and the challenge of translating mechanistic discoveries into clinical approaches.